FindTrial
Sign In

Applied Effect of Sugammadex Sodium Injection on Residual Muscle Relaxants in Post-Nanosurgery Patients

Applied Effect of Sugammadex Sodium Injection on Residual Muscle Relaxants in Post-Nanosurgery Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056013
Enrollment
Unknown
Registered
2022-01-30
Start date
2022-01-30
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General surgery

Interventions

group A:sugammadex (low dose)
group B:sugammadex (high dose)

Sponsors

Beijing You'an Hospital, Capital Medial University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.Male or female, age arranged from 18 to 85 years; 2.Meet the Barcelona Clinic Liver Cancer staging criteria; 3.Liver function child-pugh A or/and B; 4.PLT > 50 x 10^9/L; 5.Volunteering to sign informed consent.

Exclusion criteria

Exclusion criteria: 1.Upper gastrointestinal bleeding due to portal hypertension within 3 months; 2.Serious coagulation obstruction; 3.Moderate or higher ascites; 4.Uncontrolled infections: such as septicemia, biliary infection, liver abscess, etc.; 5.Serious diseases of heart, brain and kindey; 6.Prehnancy and breast-feed women; 7.Not suitable for the study.

Design outcomes

Primary

MeasureTime frame
Muscle relaxation recovery time;—

Countries

China

Contacts

Public ContactQuan Zhefeng

Beijing You'an Hospital, Capital Medical University

15811190059@126.com+86 15811190059

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026